Life Sciences

You are here

The Life Sciences sector includes companies involved in biopharmaceuticals, medical manufacturing and distribution, and bio products.

Life sciences companies listed on CSE

Nass Valley Gateway has completed the acquisition of two wholly owned subsidiaries Advanced Bioceuticals Limited (“ABL”), incorporated under the Laws of New Jersey and Pro-Thotics Technology Inc. (“PTI”), a New York corporation with a more than 25 year established business. Through its subsidiary PTI the Company will continue to focus on expanding the sale of Durable Medical Equipment (“DME-Products”)and increasing its database of more than 200,000 patients with service of providing relief from pain and medical issues via its DME-Products. Through its subsidiary ABL the Company is determined to expand upon this pain relief concept and to commence the sale of Cannabidiol (CBD) with zero THC content for internal use including CBD infused skin, bath, and body care products.

nDatalyze Corp. generates technology-based, health-related solutions. Investors are encouraged to contact the Corporation by email at jimd@ndatalyze.com or by telephone at (403) 689-3901.

NetraMark Holdings is an AI healthtech company focused on addressing both acute and non-acute brain-centric conditions. We have developed an ecosystem of innovative products that directly support brain-related conditions. Our world-renowned team and partners are disrupting traditional mental wellness treatments and are positioned at the forefront of critical research and innovations. NetraMark, a wholly owned subsidiary of NetraMark Holdings Inc., is providing proprietary next-generation AI solutions for pharmaceutical and biotechnology companies across the spectrum of disease. The company is based in Toronto, Ontario. For more information, visit https://www.netramark.com/ .

 

Nevis innovates and develops cannabis products that have been consumed by millions of consumers across multiple markets in the United States.  Led by our flagship brand Major(TM) Nevis partners with leading cannabis product manufacturers and distributors to enhance their product offerings.

The Issuer will provide consulting services, real property, intellectual property, equipment for lease and enhanced ancillary services to a licensed cannabis processor.

Nextleaf® is a federally regulated manufacturer and distributor of cannabis vapes and oils under its award-winning prohibition-era brand, Glacial Gold™. The Vancouver-based company sells its branded products through government distributors and authorized retailers in 5 provinces in Canada. Nextleaf is a low-cost producer of cannabis oils, and supplier of THC and CBD ingredients to qualified wholesale partners across Canada and internationally. Nextleaf’s patented ingredient processing technology transforms cannabis and hemp biomass into high-purity distillate at an industrial scale. The Company has been issued 19 U.S. patents, and 100 patents globally, on cannabinoid processing including extraction, distillation, and acetylation. 

For more information visit www.nextleafsolutions.com and www.Glacial.Gold

Nirvana Life Sciences Inc. is focused on developing medical products and regimens that address addiction. Nirvana is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency and other health problems.  

Nova Net Lease REIT was formed to acquire specialized industrial and retail properties leased to experienced, top-tier, creditworthy, state-licensed operators in the legal U.S. cannabis industry

Onco-Innovations Limited is a Canadian biotech company dedicated to developing and commercializing treatments for various types of cancer. The company holds an exclusive license for the PNKP Inhibitor Technology and an exclusive sublicense for the Drug Delivery Technology. Together, these technologies have shown the potential to significantly enhance treatment outcomes, particularly for colorectal cancer.

Optimi Health is the only psychedelics pharmaceutical manufacturer in Canada with both a Controlled

Drugs and Substances Dealer’s Licence and a Drug Establishment Licence (DEL). Specializing in controlled

substances such as botanical psilocybin and MDMA, Optimi is dedicated to supplying safe, top-tier GMPgrade

products and API to researchers, drug developers, and authorized patients in markets across the

world.

 

Our leadership is reinforced by our state-of-the-art, GMP-compliant cultivation, formulation, and

analytical facilities, purpose-built to develop proprietary formulations that meet the highest standards of

quality and responsible sourcing. Located in Princeton, British Columbia, our two facilities total 20,000

square feet where all products are grown and manufactured in-house under strict GACP and GMP

conditions, ensuring unparalleled quality and reliability. Optimi Health is committed to being the most

trusted and compassionate supplier of safe drug candidates worldwide.

 

Contact The Team

How can we help you?

Contact the CSE team to find out more.

Need more information?

Have questions? Leave your email and we’ll get in touch with you as soon as we can.